Cargando…
Correction to: AVT02: An Adalimumab Biosimilar
Autor principal: | Kang, Connie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617953/ https://www.ncbi.nlm.nih.gov/pubmed/36260205 http://dx.doi.org/10.1007/s40261-022-01211-0 |
Ejemplares similares
-
AVT02: An Adalimumab Biosimilar
por: Kang, Connie
Publicado: (2022) -
Social effects on AVT and CRF systems
por: Backström, Tobias, et al.
Publicado: (2021) -
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
por: Jiang, Yijia, et al.
Publicado: (2023) -
Real‐life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
por: Kapoor, Sanjiv, et al.
Publicado: (2019) -
Navigating adalimumab biosimilars: an expert opinion
por: Abitbol, Vered, et al.
Publicado: (2023)